Completed NA INTERVENTIONAL 3-arm NCT05911022

Probiotic and Colchicine in COVID-19

The Effects of Probiotic Lactobacillus Acidophilus and Colchicine on the Control of Symptoms, Duration, and Disease Progression of Mild and Moderate Cases of COVID-19: A Randomized Controlled Clinical Trial.

Sponsor: Ain Shams University

Conditions COVID-19

Interventions Colchicine 0.5 MG Probiotic Formula Standard protocol

Updated 3 times since 2023 Last updated: Jun 21, 2023 Started: Jul 1, 2021 Primary completion: Aug 30, 2022 Completion: Aug 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05911022, this NA trial focuses on COVID-19 and remains completed. Sponsored by Ain Shams University, it has been updated 3 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt